A TNFRSF14-FcɛRI-mast cell pathway contributes to development of multiple features of asthma pathology in mice
TNFSF14 (LIGHT) contributes to airway inflammation and remodelling. Here the authors show that TNFSF14 acting on its receptor TNFRSF14 on mast cells enhances their IgE-dependent activation and that interference with this pathway attenuates features of asthma pathology in mice.
Guardado en:
Autores principales: | Riccardo Sibilano, Nicolas Gaudenzio, Marianne K. DeGorter, Laurent L. Reber, Joseph D. Hernandez, Philipp M. Starkl, Oliwia W. Zurek, Mindy Tsai, Sonja Zahner, Stephen B. Montgomery, Axel Roers, Mitchell Kronenberg, Mang Yu, Stephen J. Galli |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9b661fd658a64195915d136587d50be7 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Association of TNF-α, TNFRSF1A and TNFRSF1B gene polymorphisms with the risk of sporadic breast cancer in northeast Chinese Han women.
por: Fengyan Xu, et al.
Publicado: (2014) -
Sirt1 negatively regulates FcεRI-mediated mast cell activation through AMPK- and PTP1B-dependent processes
por: Xian Li, et al.
Publicado: (2017) -
Second messenger Ap4A polymerizes target protein HINT1 to transduce signals in FcεRI-activated mast cells
por: Jing Yu, et al.
Publicado: (2019) -
Online evaluation method of coal mine comprehensive level based on FCE.
por: Ling Shen, et al.
Publicado: (2021) -
TBK1 and TNFRSF13B mutations and an autoinflammatory disease in a child with lethal COVID-19
por: Axel Schmidt, et al.
Publicado: (2021)